Privia Health Group Q1 2026: Balancing Tech Growth, Cost Discipline and Investor Sentiment
Privia Health Group’s Q1 2026 results show tech‑driven growth, yet margin pressure and costly AI upgrades test its high valuation—can strategic board moves turn the tide?
3 minutes to read